German cancer specialist Immatics has priced a $150 million public offering with Jefferies, BofA Securities, and Leerink as ...

The Food and Drug Administration (FDA) approved Genentech's Itovebi (inavolisib), in combination with palbociclib (Ibrance) ...

The UK's MHRA has approved Pfizer and BioNTech's updated COVID-19 vaccine, Comirnaty (KP.2), for use in adults. This approval ...

Berlin, Germany-based Booster Therapeutics, a biotechnology company pioneering a new class of proteasome activator medicines ...

South Korea’s Samsung Bioepis has released its Fourth Quarter 2024 Biosimilar Market Report, marking the seventh-edition of ...

Gritstone bio has filed for bankruptcy following disappointing Phase II data from its study of the personalized neoantigen ...

Nanoscope Therapeutics says that, following a productive FDA meeting with the US Food and Drug Administration (FDA) for its ...

US pharma giant Pfizer today released positive top line results from the final prespecified overall survival (OS) analysis of ...

The European Medicines Agency (EMA) has accepted for review the Marketing Authorization Applications for AVT03, a proposed ...

Insitro has signed three strategic agreements with Eli Lilly aimed at advancing treatments for metabolic diseases like MASLD, ...

Johnson & Johnson’s Tecvayli (teclistamab) has been recommended by NICE as a first-line treatment for myeloma in England and ...

China's Quantum Pharmaceuticals has announced a major licensing deal between its subsidiary Ailux Biologics and Johnson & ...